Active ingredients: estradiol + dydrogesterone
What it is used for
Hormone Replacement therapy (HRT) in oestrogen deficiency associated with natural or artificial menopause in women with an intact uteri. Prevention of postmenopausal bone mineral density loss in women. For initiation and continuation of treatment of postmenopausal symptoms, the lowest possible effective dose for the shortest duration should be used with the goal being short term use.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Oral
- Store below 30 degrees Celsius
- Lifetime is 3 Years.
Always read the label. If symptoms persist see your healthcare professional.
Round, biconvex, salmon, film-coated tablet, bearing the inscription "379" on one side.
Images are the copyright of the Pharmacy Guild of Australia
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf)
Femoston-Conti Tablets - myDr.com.au
Femoston-Conti Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
AMS Guide to Equivalent MHT/HRT Doses Australia only - Australasian Menopause Society
Information Sheet has been developed as a guideline only to approximately equivalent doses of the different MHT/HRT products available in Australia.This Information Sheet has been developed as a guideline only to approximately equivalent doses of the different HRT products available 1st August 2011. The intention is to help physicians change their patients to higher or lower approximate doses of HRT if needing to tailor therapy, or remain within the same approximate dose if needing to change brands of HRT. Products which are underlined are Australia only; products
Read more on Australasian Menopause Society website